cold sores

nanobio

NanoBio Closes $11 Million Series C Financing

NanoBio Corp. announced Wednesday the closing of an $11 million Series C financing, including full participation from its existing investor syndicate.

WWJ Newsradio 950–11/28/2012

NanoBio Gets Patent On Cold Sore Product

Ann Arbor-based NanoBio Corp. said Tuesday that it had been awarded its seventh United States patent covering its novel nanoemulsion technology. The new claims encompass methods of treating Herpes Simplex I infections, including herpes labialis, […]

08/03/2010

Follow

Get every new post delivered to your Inbox.

Join 2,328 other followers